COVID-19 Case Fatality and Alzheimer's Disease

Area of Science:

• Neurology
• Infectious Diseases
• Public Health

Background:

• Dementia is a known risk factor for COVID-19 mortality.
• The independent impact of Alzheimer's disease (AD) on COVID-19 fatality remains unclear.

Discussion:

• This study investigated the association between AD and COVID-19 mortality using a large retrospective cohort.
• Findings indicate that AD is an independent risk factor for COVID-19 case fatality.
• Vascular dementia, however, was not associated with increased COVID-19 mortality.

Key Insights:

• Alzheimer's disease patients exhibit a 1.20 times higher odds of dying from COVID-19.
• The association between AD and COVID-19 mortality persists after adjusting for demographics and comorbidities.
• No increased COVID-19 mortality was observed in patients with vascular dementia.

Outlook:

• These findings are crucial for understanding COVID-19 risk stratification in vulnerable populations.
• Further research may explore the biological mechanisms underlying AD's impact on COVID-19 outcomes.
• Public health strategies may need to consider dementia status in managing COVID-19 patients.